Within or Without You? A Perspective Comparing In Situ and Ex Situ Tissue Engineering Strategies for Articular Cartilage Repair
© 2022 The Authors. Advanced Healthcare Materials published by Wiley-VCH GmbH..
Human articular cartilage has a poor ability to self-repair, meaning small injuries often lead to osteoarthritis, a painful and debilitating condition which is a major contributor to the global burden of disease. Existing clinical strategies generally do not regenerate hyaline type cartilage, motivating research toward tissue engineering solutions. Prospective cartilage tissue engineering therapies can be placed into two broad categories: i) Ex situ strategies, where cartilage tissue constructs are engineered in the lab prior to implantation and ii) in situ strategies, where cells and/or a bioscaffold are delivered to the defect site to stimulate chondral repair directly. While commonalities exist between these two approaches, the core point of distinction-whether chondrogenesis primarily occurs "within" or "without" (outside) the body-can dictate many aspects of the treatment. This difference influences decisions around cell selection, the biomaterials formulation and the surgical implantation procedure, the processes of tissue integration and maturation, as well as, the prospects for regulatory clearance and clinical translation. Here, ex situ and in situ cartilage engineering strategies are compared: Highlighting their respective challenges, opportunities, and prospects on their translational pathways toward long term human cartilage repair.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Advanced healthcare materials - 11(2022), 24 vom: 01. Dez., Seite e2201305 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
O'Connell, Cathal D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3D bioprinting |
|---|
| Anmerkungen: |
Date Completed 23.12.2022 Date Revised 27.01.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/adhm.202201305 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350533415 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350533415 | ||
| 003 | DE-627 | ||
| 005 | 20231226045221.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/adhm.202201305 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1168.xml |
| 035 | |a (DE-627)NLM350533415 | ||
| 035 | |a (NLM)36541723 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a O'Connell, Cathal D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Within or Without You? A Perspective Comparing In Situ and Ex Situ Tissue Engineering Strategies for Articular Cartilage Repair |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.12.2022 | ||
| 500 | |a Date Revised 27.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 The Authors. Advanced Healthcare Materials published by Wiley-VCH GmbH. | ||
| 520 | |a Human articular cartilage has a poor ability to self-repair, meaning small injuries often lead to osteoarthritis, a painful and debilitating condition which is a major contributor to the global burden of disease. Existing clinical strategies generally do not regenerate hyaline type cartilage, motivating research toward tissue engineering solutions. Prospective cartilage tissue engineering therapies can be placed into two broad categories: i) Ex situ strategies, where cartilage tissue constructs are engineered in the lab prior to implantation and ii) in situ strategies, where cells and/or a bioscaffold are delivered to the defect site to stimulate chondral repair directly. While commonalities exist between these two approaches, the core point of distinction-whether chondrogenesis primarily occurs "within" or "without" (outside) the body-can dictate many aspects of the treatment. This difference influences decisions around cell selection, the biomaterials formulation and the surgical implantation procedure, the processes of tissue integration and maturation, as well as, the prospects for regulatory clearance and clinical translation. Here, ex situ and in situ cartilage engineering strategies are compared: Highlighting their respective challenges, opportunities, and prospects on their translational pathways toward long term human cartilage repair | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a 3D bioprinting | |
| 650 | 4 | |a biomaterials | |
| 650 | 4 | |a cartilage tissue engineering | |
| 650 | 4 | |a in situ tissue engineering | |
| 650 | 4 | |a stem cells | |
| 650 | 7 | |a Biocompatible Materials |2 NLM | |
| 700 | 1 | |a Duchi, Serena |e verfasserin |4 aut | |
| 700 | 1 | |a Onofrillo, Carmine |e verfasserin |4 aut | |
| 700 | 1 | |a Caballero-Aguilar, Lilith M |e verfasserin |4 aut | |
| 700 | 1 | |a Trengove, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Doyle, Stephanie E |e verfasserin |4 aut | |
| 700 | 1 | |a Zywicki, Wiktor J |e verfasserin |4 aut | |
| 700 | 1 | |a Pirogova, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Di Bella, Claudia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advanced healthcare materials |d 2012 |g 11(2022), 24 vom: 01. Dez., Seite e2201305 |w (DE-627)NLM218710070 |x 2192-2659 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:24 |g day:01 |g month:12 |g pages:e2201305 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/adhm.202201305 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2022 |e 24 |b 01 |c 12 |h e2201305 | ||